esomeprazole + placebo
Pre-clinicalCompleted 0 watching 0 views this week๐ค Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Vasomotor Rhinitis
Conditions
Vasomotor Rhinitis
Trial Timeline
Jun 1, 2005 โ Mar 1, 2008
NCT ID
NCT00745849About esomeprazole + placebo
esomeprazole + placebo is a pre-clinical stage product being developed by AstraZeneca for Vasomotor Rhinitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00745849. Target conditions include Vasomotor Rhinitis.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (7)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01069939 | Phase 3 | Completed |
| NCT00660660 | Approved | Completed |
| NCT00542789 | Phase 3 | Completed |
| NCT00287339 | Approved | Completed |
| NCT00745849 | Pre-clinical | Completed |
| NCT00628953 | Phase 2 | Completed |
| NCT00628667 | Approved | Completed |
Competing Products
20 competing products in Vasomotor Rhinitis